The FDA has granted Fast Track designation to the investigational antibody-drug conjugate (ADC) SIM0505 for the treatment of women with platinum-resistant ovarian cancer. The designation adds SIM0505 ...
The Agriculture Department's rewrite of NEPA regulations pushes for quicker approvals of a range of projects on federal land.
Stenoparib, targeting PARP1/2 and tankyrase 1/2, offers a unique mechanism for treating advanced ovarian cancer. The FDA's fast track designation facilitates expedited development and review, with ...
By Emma Rumney and Patrick Wingrove LONDON/NEW YORK, April 1 (Reuters) - Popular nicotine pouch products have yet to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results